Main > WOMEN HEALTH > Precocious Puberty>Central > Treatment > Co: CH. D. Triptorelin 6-Month Form



Co: CH. D. Triptorelin 6-Month Form's subsections
(*) EU Approval Date: 2017. 01.09
(*) USA Approval Date: 2017. 06.30
Company
Company Licensee USA
GnRH agonist formulation
TradeMark (EU)
TradeMark (EU) Web-Site
TradeMark (USA)

Co: CH. D. Triptorelin 6-Month Form's products
This section has no products